Navigation Links
Pharma IQ's Compound Management Survey Report
Date:3/14/2012

LONDON, March 14, 2012 /PRNewswire/ --

Pharma IQ has just published the results of an industry-wide Compound Management Survey, conducted recently among 4,000 compound management specialist with nearly half of those questioned having a library or sample management team responsible for biological materials or samples.

According to the survey results, 66.7 per cent of the professionals in the field cited three areas as primary concerns in their current role or department: the quality of samples, which can deteriorate during transport, the management of sample data and the huge need to construct new libraries to meet their new research.

With regard to the biggest challenges in handling biological samples or materials, the study revealed that quality perseverance, safeguarding of sample quality as well introducing an effective ID and tracking system was their key priority.

The survey was created as a part of the pre-conference research for Compound and Sample Management Forum taking place 21-23 May, 2012 in Amsterdam.

The results helped to shape the agenda and final speaker line-up which features Stuart Ratcliffe, Senior Scientist (Projects), Screening Sciences & Sample Management from AstraZeneca explaining the Automation in Compound Management employed at Astra Zeneca and Ling Santora, Senior Scientist, Bioresearch Centre from Abbott leading a session on The Biologics Pharmacy - Ensuring High Quality of Protein Reagents to Support Biologics Drug Discovery and Research at Abbott.

Other important topics expressed by survey respondents that will be discussed at the event include:

  • Management of in-vitro synthesized and in-vivo RNAi Reagents at the Drosophila RNAi Screening (Stephanie Mohr PhD, Director of the Drosophila RNAi Screening Center, Harvard Medical School)
  • Sample management workflows and supporting software (Janet Diratsaoglu, Principal Scientist, Roche)
  • Building a cDNA and RNAi library management system (Karen Billeci Scientific Manager, Assay & Automation Technology Group Genentech)
  • Library strategies: A model for academic/industrial collaboration in drug discovery: the rare paediatric brain tumour campaign at St. Jude Children's Research Hospital (Anang Shelat, Director, Lead Discovery Informatics and Compound Management, Department of Chemical Biology and Therapeutics
    St. Jude Children's Research Hospital)

To access the full survey report or to find out more about  Compound and Sample Management   please visit http://www.compoundmanagercom/NEWS, emailenquire@iqpc.co.uk or call +44(0)20-7036-1300

Media contact: Joanna, +44(0)20-7368-9421, joanna.checinska@iqpc.co.uk - Please contact for more information or images.

Press are invited to attend this important industry forum, if you would like to a complimentary press pass please email Joanna Checinska (jaonna.checinska@iqpc.co.uk)



'/>"/>
SOURCE Pharma IQ
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2011 Financial Results on March 12, 2012
2. PharmAthene to Present at the 24th Annual ROTH Conference on Monday, March 12, 2012
3. Enox Biopharma, Inc. Will Present at IN360 Investment in Innovation Conference
4. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results
5. PDL BioPharma Announces Fourth Quarter and Full Year 2011 Financial Results
6. Onyx Pharmaceuticals to Present at Upcoming Investor Conferences
7. Avanir Pharmaceuticals to Participate in Citi 2012 Global Health Care Conference
8. Swedish Bactiguard to Enter Into an Exclusive Distribution Agreement With Cadila Pharmaceuticals
9. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2011 Financial Results on Wednesday, March 7, 2012
10. BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals
11. Laureate Biopharma Appoints Les Mintzmyer, Vice President, Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Franz Inc ., ... development tools, and market leader for Semantic Graph Database technology, today ... within the most effective system for developing and deploying applications to solve the ...
(Date:4/25/2017)... R.I. , April 25, 2017 ... Inc. ("EpiVax") has licensed its novel immune-modulating technology to ... autoimmune disease and allergy. Tregitopes, pronounced ... in human immunoglobulin by EpiVax CEO Annie ... Similar to intravenous immunoglobulin G, an autoimmune disease ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... , Covalent’s Analytical Services unit provides high-quality data to clients, both ... 24 hours of receipt. There are no price premiums, and customers are welcome ...
(Date:4/24/2017)... ... April 24, 2017 , ... It is well ... milieu; however, the broad application of this cellular target engagement concept to drug ... readouts. Cell-based thermal stabilization assays are valuable methods for particular applications, but they ...
Breaking Biology Technology:
(Date:3/23/2017)... 23, 2017 Research and Markets has announced ... & Trends - Industry Forecast to 2025" report to their ... The ... CAGR of around 8.8% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
(Date:3/20/2017)... 20, 2017 PMD Healthcare announces the release ... Wellness Management System (WMS), a remote, real-time lung health ... PMD Healthcare is a Medical Device, Digital Health, and ... to creating innovative solutions that empower people to improve ... focus, PMD developed the first ever personal spirometer, Spiro ...
(Date:3/7/2017)... March 7, 2017 Brandwatch , the leading social ... The Prince,s Trust to uncover insights to support its reporting, ... The UK,s leading youth charity will be using Brandwatch ... and get a better understanding of the topics and issues that ... ...
Breaking Biology News(10 mins):